Thirteen proteomics service and product providers have formed a new organization this week that aims to provide "sample to discovery" solutions for all stages of proteomics research, and to address "critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring," it said in a statement.
The group, called Proteomics Innovation Network, comprises: ProFACT Proteomics, Norton Scientific, Eprogen, Neolomed Biosciences, Focus Proteomics, New England Peptide, Ontario Cancer Biomarker Network, Innova Proteomics, Dualsystems Biotech, NewLibertyProteomics, Horluce BioConsulting, the Australian Proteome Analysis Facility, and Covaris.